Showing 4 posts of 4 posts found.

Nanobiotix announces license agreement with Janssen for development and commercialisation of new cancer treatment

July 10, 2023
Sales and Marketing Cancer, Janssen, License Agreement, Oncology, nanobiotix

Nanobiotix has announced a global licensing, co-development and commercialisation agreement with Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies …

Nanobiotix enters final contract negotiations with major pharma company

May 5, 2023
Medical Communications FDA, Oncology, nanobiotix, oncology

French late-stage clinical biotechnology company Nanobiotix has announced that it has entered into final contract negotiations with a major pharmaceutical …


Nanobiotix appoints head from Roche

April 22, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, nanobiotix, otin

France-based clinical-stage nanomedicine firm Nanobiotix has hired Thierry Otin as its head of manufacturing and supply. Prior to joining Nanobiotix, …


Nanobiotix appoints ex-Sanofi head Alain Herrera

February 14, 2013
Manufacturing and Production, Research and Development, Sales and Marketing Sanofi, nanobiotix

Nanomedicine firm Nanobiotix has announced that Dr Alain Herrera joins its Supervisory Board, succeeding Thierry Chopin and Isabelle Bou Antoun …

Latest content